MILFORD, Mass.--(BUSINESS WIRE)--At a recent ceremony at Taipei’s Chang Gung University (CGU), Waters Corporation welcomed the University’s Healthy Aging Research Center as a Waters Centers of Innovation (COI) Program partner - the first in Taiwan.
The Waters COI Program recognizes analytical scientists facilitating breakthroughs in health and life science research, food safety, environmental protection, sports medicine and other areas through the use of liquid chromatography and mass spectrometry.
Led by Dr. Daniel Tsun-Yee Chiu, Ph.D., Dean of Research & Development, and director of CGU’s Healthy Aging Research Center, the Center focuses on the implementation of advanced analytical science to answer key questions on the mechanisms of disease that affect human health, particularly in the elderly. Dr. Chiu has a special interest in the effects of oxidative stress on cellular function and establishing reference laboratories to assess oxidative stress and antioxidant capacity in health and in diseases. He is currently the president of the Society of Free Radical Research-Asia and he has published over 140 scientific articles along this area.
Dr. Chiu expressed his deep gratitude that CGU’s Healthy Aging Research Center has been selected to become a Waters Center of Innovation partner.
“We are truly honored to become Waters Corporation’s COI partner in Taiwan. I am confident that the research conducted with the assistance of Waters’ technology will lead to breakthroughs that will greatly advance the study of various degenerative diseases and their impact on human health. I would like to once more extend our thanks to Waters for their recognition of our research,” said Dr. Chiu.
Attending the ceremony was Dean Yu, General Manager of Waters Taiwan, who extended his congratulations on behalf of Waters to Dr. Chiu and his team.
“Dr. Chiu and his colleague, Professor Ming-Shi Shiao have been advocates, technical advisors, and pioneers in the field of metabolomics, metabolite I.D. and profiling in Taiwan for many years. Their considerable influence within CGU, as well as other major Taiwanese and international institutes is well deserved. On behalf of all Waters employees, we are excited that Chiu’s team is now a Waters COI partner," said Yu.
The Centers of Innovation Program ceremony was held in conjunction with a symposium, “Metabolomics from Bench to Bedside” which was co-organized by Chang Gung University and Waters Corporation and featured presentations by Professor Jeremy Nicholson, Imperial College London; Professor David Wishart, University of Alberta; Professor Kumar Sharma, University of California San Diego; Professor David Herold and Professor Liang Li, University of Alberta.
Metabolomics is the study of molecules known as metabolites that are produced by living organisms as the result of biological processes. Metabolites have been used as biomarkers for decades. The presence of sugar in urine as a diagnostic test for diabetes is one of the oldest examples. Mass spectrometry is an extremely sensitive means of studying the full array of metabolites produced by an organism. From a few microliters of blood or extract scientists are beginning to learn a great deal about the biological underpinnings of disease processes, the response of an organism like a plant to an environmental stress or the response of a test subject to the administration of a drug simply by measuring the type and concentration of metabolites present.
About Chang Gung University
Chang Gung University (CGU) was first established in April 1987 as the Chang Gung Medical College and later renamed Chang Gung University in July 1997. Currently, the university has approximately 600 full-time faculty members, and has more than 7,400 students enrolled. CGU has been striving for excellence in both instruction and research area. In order to educate and shape students to be “diligent, perseverant, frugal, and trustworthy” and well-versed in both theory and practice, CGU has instituted an extracurricular practicum system and been working closely with Chang Gung Memorial Hospital, the Formosa Plastics Group, and other institutions to conduct work-study programs as well as practical training. In taking advantage of Formosa Plastics Group's abundant manufacturing and medical service resources, CGU aims to be a first-rate internationally renowned university that prepares high standard professional talents in the fields of medical sciences, engineering, and management. In 2014, CGU has been selected as top 500 Universities in Academic Ranking of World Universities (ARWU) for the 7th consecutive year and CGU is ranked 5th among all universities in Taiwan.
About Waters Centers of Innovation Program
Waters Centers of Innovation Program recognizes and supports the efforts of scientists facilitating breakthroughs in health and life science research, food safety and food science, environmental protection, sports medicine and many other areas. Waters provides scientists and their institutions in the Program with early access to pre-commercialized novel technology that may lead to scientific breakthroughs and jump-start a research project. In other instances, collaborative efforts between Waters experts applications scientists and Program participants have accelerated research in important ways.
In addition to Dr. Chiu, other researchers and research centers recognized by the Waters Centers of Innovation Program include: Professor Ganesh Anand, National University of Singapore; Professor Luiz Claudio Cameron, UniRio, Brazil; Professor David Clemmer, Indiana University; Professor Daniel Tsun-Yee Chiu, Chang Gung University; Dr. Joseph Dalluge, University of Minnesota; Dr. Petur Weihe Dalsgaard, University of Copenhagen; Professor Marcos Eberlin, University of Campinas, Brazil; Prof. Chris Elliott, Queen’s University Belfast; Professor John Engen, Northeastern University; Professor Albert J. Fornace, Jr., Georgetown Lombardi Comprehensive Cancer Center; Professor David Goodlett and Dr. Maureen Kane, University of Maryland School of Pharmacy; Professor De-an Guo, Shanghai Institute of Materia Medica; Dr. Frank Gonzalez, National Cancer Institute; Dr. Carlo R. Largiadèr, Inselspital University Hospital; Professor Julie Leary of the University of California – Davis; Professor Amit Kumar Mandal, St. John’s Research Institute, Bangalore, India; Professor John McLean, Vanderbilt University; Professor Arthur Moseley, Duke University; Professor Jeremy Nicholson, Imperial College London; Dr. Devin Peterson, University of Minnesota; Assistant Professor Jessica Prenni, Colorado State University; Dr. Serge Rezzi, Nestle Institute of Health Sciences; Dr. Ryan Rogers, Future Fuels Institute, Florida State University; Professor Pauline Rudd, National Institute for Bioprocessing Research and Training; Professor James Scrivens, University of Warwick; Professor Vladimir Shulaev, University of North Texas; Dr. Norman Smith, Kings College London; Professor Sarah Trimpin, Wayne State University; Professor Bert van Bavel, Örebro University, Örebro, Sweden; Caroline West and Eric Lesselier, University of Orleans, Orleans, France; and Professor Vicki Wysocki, Ohio State University.
About Waters Corporation (www.waters.com)
For more than 50 years, Waters Corporation (NYSE:WAT) has created business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, water quality, consumer products, and high value-added chemicals worldwide.
Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.
Waters, Synapt, XEVO, ACQUITY UPLC, and ACQUITY are trademarks of Waters Corporation.